Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination intervention consisting of oral vitamin D supplementation and a "sham exercise" protocol. Vitamin D is a fat-soluble secosteroid hormone involved in calcium and phosphate homeostasis, bone health, and immune modulation. In clinical trials, the vitamin D regimen typically consists of cholecalciferol (vitamin D3) administered at 10,000 IU three times weekly for 20 weeks[2][3]. The "sham exercise" component refers to an activity designed to mimic the structure or time commitment of an active exercise intervention but without providing its physiological benefits; it serves as a control condition in randomized controlled trials. Sham exercises may include low-intensity balance or toning routines that do not significantly improve aerobic capacity or muscle strength[2][3]. This combination is used as a comparator arm in studies investigating the effects of vitamin D and/or structured exercise on cognitive function, physical performance, or other health outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin d + sham exercise.